{"infobox":{"dc_creator":"WooScraper_v1","dc_date_year":2012,"dc_identifier":"nl.oorg10123.2j.2012.843","dc_publisher":"oorg10123","dc_publisher_name":"Rijksinstituut voor Volksgezondheid en Milieu","dc_source":"https://www.rivm.nl/publicaties/spatially-explicit-prioritization-of-human-antibiotics-and-antineoplastics-in-europe","dc_title":"Spatially explicit prioritization of human antibiotics and antineoplastics in Europe | RIVM","dc_type":"2j","dc_type_description":"2j - Onderzoek","foi_extraMetadata":{},"foi_files":[],"foi_isWoo":"Ja","foi_page_title":"Onderzoek Rijksinstituut voor Volksgezondheid en Milieu","foi_publishedDate":"2012-11-20","foi_retrievedDate":"2024-12-01","tooiwl_type":"c_fdaee95e"},"resource":"nl.oorg10123.2j.2012.843"}